7 of 11 biosimilars approved in Korea were developed by Korean company
It was reported there were the total 11 biosimilar products approved in Korea, such as ‘Remsima 100mg,’ and 7 of them were developed by Korean pharmaceutical companies.
According to the Ministry of Food and Drug Safety(MFDS), after Celltrion’s ‘Remsima 100mg’ was first approved as a biosimilar o...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.